Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2001
10/09/2001CA2119662C New nitrogen bicyclic derivatives, their preparation process and pharmaceutical compositions comtaining them
10/09/2001CA2029787C Method for preparation of taxol using an oxazinone
10/09/2001CA2018960C Salicylaldehyde derivatives and salicylic acid derivatives and their sulfur analogs, their preparation and their use as herbicides and bioregulators
10/04/2001WO2001072737A1 Triarylimidazole derivatives as cytokine inhibitors
10/04/2001WO2001072723A1 Oxa(thia)zolidine derivative and anti-inflammatory drug
10/04/2001WO2001072719A1 Method for producing asymmetrical 4,6-bis(aryloxy)pyrimidine derivatives
10/04/2001WO2001072711A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001WO2001021577A3 Melanin concentrating hormone antagonist
10/04/2001WO2000034255A9 Substituted thiazoles for treatment of human diseases involving modulators of p-, l- and e- selectin
10/04/2001WO2000033836A9 5-membered heterocycles for the treatment of human diseases involving modulators of selectins
10/04/2001US20010027207 Modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation; anticarcinogenic, -diabetic, -proliferative and -inflammatory agents; vascular system disorders
10/04/2001US20010027200 PPARgamma modulators
10/04/2001US20010027196 Adenosine receptor ligands and their use in the treatment of disease
10/04/2001US20010027194 Novel compounds useful as neuro-protective agents
10/04/2001EP1137642A1 Bis-sulfonamides
10/04/2001EP1087962A4 Preparation of heteroaryl compounds
10/04/2001EP0975631B1 5-aryl-3-(8-azabicyclo[3.2.1]oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands
10/04/2001EP0842174B1 Heterocyclic compounds for treating myocardial ischaemia
10/04/2001EP0840721B1 Carboxylic acid amide derivatives and their use as pesticides
10/04/2001DE19947154A1 Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
10/04/2001CA2404662A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/03/2001CN1315951A FKBP inhibitors
10/03/2001CN1315942A 2-oxo-j(2H)-quinoline derivatives
10/03/2001CN1315320A Ether and amide compounds as medicide for treating glycuresis and preparing process thereof
10/03/2001CN1072223C Halogen pyrimidines, its preparing process and pesticide containing same
10/03/2001CN1072222C Phenyloxazolidinones having C-C bond to 4-8 membered heterocyclic rings
10/03/2001CN1072221C 3-halo-3-heteroaryl carboxylic acid derivatives, method of preparing them and intermediates
10/03/2001CN1072210C 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors
10/02/2001US6297376 Potent and selective substance p (or neurokinin-1) receptor antagonists. one-step alkylation with 3-chloromethyl-1,2,4-triazolin-5-one,
10/02/2001US6297375 4-phenyl-pyridine derivatives
10/02/2001US6297374 Nitroimino-nitromethylene—azole or-azine heterocyclic compounds, insecticidal compositions containing them, and insecticidal methods of using them
10/02/2001US6297269 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
10/02/2001US6297267 Prostaglandin i2 agonist.
10/02/2001US6297246 Benzoxazole derivatives; does not cause constipation as a side effect.
10/02/2001US6297242 Active against methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococci and penicillin- and cephalosporin-resistant streptococcus pneumoniae.
10/02/2001US6297198 Compounds with sulfur groups on isoxazole rings as herbicides
10/02/2001US6297196 Benzoyl derivatives, process for their preparation and their use as herbicides and plant growth regulators
10/02/2001CA2207835C New derivatives of 3-(piperid-4-yl) 1,2-benzisoxazole and 3-(piperazin-4-yl) 1,2-benzisoxazole, their preparation processes and the pharmaceutical compositions they contain
09/2001
09/27/2001WO2001070734A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
09/27/2001WO2001070733A2 Di-substituted iminoheterocyclic compounds
09/27/2001WO2001070731A1 Decahydro-isoquinolines
09/27/2001WO2001070708A1 Substituted piperidines as melanocortin receptor agonists
09/27/2001WO2001070706A2 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
09/27/2001WO2001070690A1 Heterocyclic side chain containing metalloprotease inhibitors
09/27/2001WO2001070677A1 Sulphonamido-substituted bridged bicycloalkyl derivatives
09/27/2001WO2001070674A1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
09/27/2001WO2001070673A2 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a)
09/27/2001WO2001032654A3 Novel heterocyclic compounds and their use as medicines
09/27/2001WO2001017972A3 Novel herbicides
09/27/2001WO2001014576B1 Process and intermediates for the preparation of isoxazolecaroxamides and analogues
09/27/2001DE10014607A1 Production of asymmetric 4,6-bis(aryloxy)-pyrimidine derivatives comprises two stage reaction of 4,6-dichloro-pyrimidine with phenols using 1,4-diazabicyclo(2.2.2)octane in second reaction stage
09/27/2001DE10014006A1 New heterocyclic acylsulfimide derivatives, useful as insecticides, acaricides and nematocides for plant protection or in veterinary medicine
09/27/2001CA2404076A1 Heterocyclic side chain containing metalloprotease inhibitors
09/27/2001CA2401870A1 Cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-.alpha.
09/27/2001CA2400168A1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
09/27/2001CA2400000A1 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
09/27/2001CA2364268A1 Di-substituted iminoheterocyclic compounds
09/26/2001EP1136071A2 Use of glycogen phosphorylase inhibitors
09/26/2001EP1135388A2 3-(heterocyclyl)-substituted benzoylpyrazols
09/26/2001EP1135387A2 3-(heterocyclyl)-benzoylpyrazole-derivatives
09/26/2001EP1135371A1 Beta-alanine derivatives as alpha 4 integrin inhibitors
09/26/2001EP1135370A2 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
09/26/2001EP1135151A1 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
09/26/2001CN1314899A Retinoid-associated receptor regulators
09/26/2001CN1314891A Synthesis of benzo (F) quinolinones
09/26/2001CN1314813A Novel isoxazolinone antibacterial agent
09/26/2001CN1314345A Novel piperidine-4-sulfamide compound, its preparing method and medicinal composition containing them
09/26/2001CN1071757C Pyrazol benzoyl derivatives
09/26/2001CN1071753C 7-azabicyclo [2,2,1]-heptane and heptene derivatives as cholinergic receptor ligands
09/25/2001US6294580 For therapy and prophylaxis of type ii or non-insulin dependent diabetes mellitus, hyperglycaemia, dyslipidemia, type ii diabetes, type i diabetes, hypertriglyceridemia, syndrome x, insulin resistance, heart failure
09/25/2001US6294564 Benzimidazoles and benzoxazoles
09/25/2001US6294561 Cyclic AMP-specific phosphodiesterase inhibitors
09/25/2001US6294558 Antiinflammatory agents and prostaglantins
09/25/2001US6294551 N-linked sulfonamides of heterocyclic thioesters
09/25/2001US6294542 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same
09/25/2001US6294536 Triazine derivatives, their production and use
09/25/2001US6294503 Herbicidal compositions containing heterocycles
09/25/2001US6294112 Red coloring hyperchromic 3H-naphtho[2,1-B]pyrans
09/25/2001CA2029132C Sulphonylaminocarbonyltriazolinones having substituents which are bonded via sulphur
09/22/2001CA2341344A1 Use of glycogen phosphorylase inhibitors
09/20/2001WO2001068647A1 Medicaments against viral diseases
09/20/2001WO2001068641A1 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viral diseases
09/20/2001WO2001068619A1 5-amide substituted diarylamines as mex inhibitors
09/20/2001WO2001068613A1 Pyrimidinone derivatives and herbicides
09/20/2001WO2001068612A2 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
09/20/2001US20010023250 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
09/20/2001US20010023248 Antiinflammatory agents, central nervous system disorders
09/20/2001DE10013126A1 New 6-aminoalkyl-dihydropyrimidine-5-carboxylate ester derivatives, useful as antiviral agents having strong activity against hepatitis B virus and low cytotoxicity
09/20/2001DE10012549A1 New heterocyclic-substituted dihydropyrimidine derivatives useful for treatment of viral infections, especially hepatitis B infections
09/20/2001CA2403017A1 5-amide substituted diarylamines as mex inhibitors
09/19/2001EP1134220A1 Benzoxazole derivatives and drugs containing the same as the active ingredient
09/19/2001EP1134214A1 Picolinamide derivatives and pest controllers containing the same as the active ingredient
09/19/2001EP1134213A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides
09/19/2001EP1133493A1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
09/19/2001EP1133484A2 Heterocyclic derivatives and their use as integrin inhibitors
09/19/2001EP1133483A1 Il-5 inhibiting 6-azauracil derivatives
09/19/2001EP1133482A1 Il-5 inhibiting 6-azauracil derivatives
09/19/2001EP1133481A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
09/19/2001EP1133294A1 Compositions and methods for the treatment of alzheimer's disease, central nervous system injury, and inflammatory diseases
09/19/2001CN1313855A Inhibitors of alpha4Betal mediated cell adhesion alpha Beta